洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100042645】Dr. Muhammad Usman Javed: please fill in the date of approved by ethic committee. COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CO

基本信息
登记号

ChiCTR2100042645

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-01-24

临床申请受理号

/

靶点

/

适应症

肾石症

试验通俗题目

Dr. Muhammad Usman Javed: please fill in the date of approved by ethic committee. COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CO

试验专业题目

COMPARISON OF POST-OPERATIVE ANALGESIA WITH PERI TRACT LOCAL ANESTHESIA INFILTRATION AND ORAL ANALGESIA VERSUS POST-OPERATIVE INTRAVENOUS ANALGESIA AFTER PERCUTANEOUS NEPHROLITHOTOMY. A RANDOMIZED CONTROLLED TRIAL.

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

60000

联系人通讯地址
临床试验信息
试验目的

To compare peri tract infiltration of Bupivacaine augmented by oral post-operative analgesia versus post-operative intravenous analgesia alone in patients undergoing percutaneous nephrolithotomy in terms of mean post-operative pain score

试验分类
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

lottery method

盲法

Not stated

试验项目经费来源

None

试验范围

/

目标入组人数

34

实际入组人数

/

第一例入组时间

2019-04-11

试验终止时间

2019-10-10

是否属于一致性

/

入选标准

a. All patients undergoing PCNL; b. Age from 12-65 years; c. Normal Renal Functions; d. No history of chronic pain; e. ASA I, II & III; f. Both genders.;

排除标准

a. History of local anesthesia allergy; b. Redo PCNL; c. Multiple punctures during PCNL; d. Excessive intra-operative bleeding; e. Diabetes Mellitus; f. Coagulopathy; g. Mental Disorder; h. ASA IV & V; i. Active urinary tract infection.;

研究者信息
研究负责人姓名
试验机构

None

研究负责人电话
研究负责人邮箱
研究负责人邮编

60000

联系人通讯地址
<END>

None的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验